Gennaro Marco Falco

11PUBLICATIONS
48CO-AUTHORS
AutoimmunityPharmaceutical delivery technologiesPsychiatry (incl. psychotherapy)AllergyChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 30, 2026
Superior Clinical and Economic Value of IL-23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis.

Gennaro Marco Falco, Elena Ippoliti, Niccolò Gori

|Oct 07, 2024
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies.

Giacomo Caldarola, Eleonora De Luca, Gennaro Marco Falco

|Oct 02, 2024
Eczematous eruption during bimekizumab treatment in a psoriatic patient previously treated with secukinumab.

Gennaro Marco Falco, Giacomo Caldarola, Alessandra D'Amore

|Feb 27, 2024
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).

Diego Orsini, Giacomo Caldarola, Annunziata Dattola

|Feb 25, 2024
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients.

Giacomo Caldarola, Daniele O Traini, Gennaro M Falco

Pageof 2